Enlivex Therapeutics

Technology 📍 Israel 👥 11-50 employees 💰 $7.0M raised 📅 Founded 2005

Enlivex is an Israeli-based cell immunotherapy company established in October 2005 by Professor Dror Mevorach, a world-renowned expert on clearance of dying (apoptotic) cells. Enlivex is developing an autologous and allogeneic drug pipeline for the treatment of autoimmune and inflammatory conditions such as Graft versu

🌐 Website ← All Companies

📊 Company Overview

Sector

Technology

Country

Israel

Employees

11-50

Total Raised · Debt

$7.0M

Founded

2005

Cloud

Unknown

Email

Microsoft 365

☁️ Cloud Infrastructure

🔒 Subscribers only Cloud Provider

Workspace	Microsoft 365
CDN	🔒 Subscribers only

Detected via DNS records and HTTP response headers as of 2026-06-13.

💰 Estimated Cloud Spend

$216K – $540K / year across cloud providers

🛠 Tech Stack & Marketing

Ad Platforms	🔒 Subscribers only
Analytics & CRM	🔒 Subscribers only
CMS / Platform	WordPress
Frontend Stack	🔒 Subscribers only

Detected from Enlivex Therapeutics's public homepage as of 2026-06-13.

🔍 Compare with Similar Companies

Same sector (Technology), similar size

1-10 ☁️ Vercel

FleetCor Technologies

1-10 ☁️ Unknown

11-50 ☁️ Unknown

Data detected 2026-06-13 · Methodology · Suggest a correction